An Immunomodulatory Hydrogel by Hyperthermia‐Assisted Self‐Cascade Glucose Depletion and ROS Scavenging for Diabetic Foot Ulcer Wound Therapeutics

Xiaoliang Qi, Erya Cai, Yajing Xiang, Chaofan Zhang, XinXin Ge, Jiajia Wang, Yulong Lan, Hangbin Xu, Rongdang Hu, Jianliang Shen

Advanced Materials · 2023 · 358 citations · 25 references

DOIFull text

Open access

Concepts

TL;DR

Diabetic foot ulcers are a severe, rapidly growing complication driven by hyperglycemia‑induced inflammation and excessive reactive oxygen species that reinforce each other, yet current therapies fail to target both aspects. This study proposes an immunomodulatory hydrogel that self‑cascades glucose depletion and ROS scavenging to regulate the diabetic microenvironment. The AuPt@melanin‑incorporated hydrogel (GHM3) delivers hyperthermia‑enhanced local glucose depletion and ROS scavenging. In vitro, in vivo, and RNA‑seq data show that GHM3 disrupts the ROS‑inflammation cycle, shifts macrophage polarization toward M2, and improves healing of dorsal skin and DFU wounds in diabetic rats, offering a safe, efficient treatment.

Abstract

Abstract Current therapeutic protocols for diabetic foot ulcers (DFUs), a severe and rapidly growing chronic complication in diabetic patients, remain nonspecific. Hyperglycemia‐caused inflammation and excessive reactive oxygen species (ROS) are common obstacles encountered in DFU wound healing, often leading to impaired recovery. These two effects reinforce each other, forming an endless loop. However, adequate and inclusive methods are still lacking to target these two aspects and break the vicious cycle. This study proposes a novel approach for treating DFU wounds, utilizing an immunomodulatory hydrogel to achieve self‐cascade glucose depletion and ROS scavenging to regulate the diabetic microenvironment. Specifically, AuPt@melanin‐incorporated (GHM3) hydrogel dressing is developed to facilitate efficient hyperthermia‐enhanced local glucose depletion and ROS scavenging. Mechanistically, in vitro/vivo experiments and RNA sequencing analysis demonstrate that GHM3 disrupts the ROS‐inflammation cascade cycle and downregulates the ratio of M1/M2 macrophages, consequently improving the therapeutic outcomes for dorsal skin and DFU wounds in diabetic rats. In conclusion, this proposed approach offers a facile, safe, and highly efficient treatment modality for DFUs.

References

25